Human aging is associated with parallel reductions in insulin and amylin release

American Journal of Physiology - Endocrinology and Metabolism

Volumn 275, Issue 5 38-5, 1998, Pages

  Dechenes, Cynthia J ^c   Verchere, C Bruce ^a   Andrikopoulos, Sofianos ^b   Kahn, Steven E ^c  

^a CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c VA Puget Sound Hlth Care S ^*

Author keywords

B cell; Body adiposity; Glucose; Insulin sensitivity; Islet amyloid polypeptide

Indexed keywords

AMYLIN; GLUCOSE; INSULIN;

ADIPOSE TISSUE; AGED; AGING; ARTICLE; B LYMPHOCYTE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN SECRETION;

EID: 0031790302     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1998.275.5.e785     Document Type: Article

References (20)

1. Beard, J. C., J. B. Halter, J. D. Best, M. A. Pfeifer, and D. Porte, Jr. Dexamethasone-induced insulin resistance enhances B cell responsiveness to glucose level in normal men. Am. J. Physiol. 247 (Endocrinol. Metab. 10): E592-E596, 1984.
2. Bell, E. T. Hyalinization of the islets of Langerhans in nondiabetic individuals. Am. J. Pathol. 35: 801-805, 1959.
3. Bergman, R. N., Y. Z. Ider, C. R. Bowden, and C. Cobelli. Quantitative estimation of insulin sensitivity. Am. J. Physiol. 236 (Endocrinol. Metab. Gastrointest. Physiol. 5): E667-E677, 1979.
4. Bergman, R. N., L. S. Phillips, and C. Cobelli. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J. Clin. Invest. 68: 1456-1467, 1981.
5. Butler, P. C., J. Chou, W. B. Carter, Y.-N. Wang, B.-H. Bu, D. Chang, J.-K. Chang, and R. A. Rizza. Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 39: 752-756, 1990.
6. Chen, M., R. N. Bergman, G. Pacini, and D. Porte, Jr. Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased β-cell function. J. Clin. Endocrinol. Metab. 60: 13-20, 1985.
7. Clark, A., C. A. Wells, I. D. Buley, J. K. Cruickshank, R. I. Vanhegan, D. R. Matthews, G. J. S. Cooper, R. R. Holman, and R. C. Turner. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res. 9: 151-159, 1988.
8. Cooper, G. J. S. Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. Endocr. Rev. 15: 163-201, 1994.
9. Cooper, G. J. S., A. C. Willis, A. Clark, R. C. Turner, R. B. Sim, and K. B. M. Reid. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc. Natl. Acad. Sci. USA 84: 8628-8632, 1987.
10. Davidson, M. B. The effect of aging on carbohydrate metabolism: a review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly. Metabolism 28: 687-705, 1979.
11. DeFronzo, R. A. Glucose intolerance of aging. Evidence for tissue insensitivity to insulin. Diabetes 28: 1095-1101, 1979.
12. Edwards, B. J., H. M. Perry, F. E. Kaiser, J. E. Morley, D. Kraenzle, D. K. Kreutter, and R. W. Stevenson. Age-related changes in amylin secretion. Mech. Ageing Dev. 86: 39-51, 1996.
13. Enoki, S., T. Mitsukawa, J. Takemura, M. Nakazato, J. Aburaya, H. Toshimori, and S. Matsukara. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabetes Res. Clin. Pract. 15: 97-102, 1992.
14. Gedulin, B., G. J. S. Cooper, and A. A. Young. Amylin secretion from the perfused pancreas: dissociation from insulin and abnormal elevation in insulin-resistant diabetic rats. Biochem. Biophys. Res. Commun. 180: 782-789, 1991.
15. Hartter, E., T. Svoboda, B. Ludvik, M. Schuller, B. Lell, E. Kuenburg, M. Brunnbauer, W. Woloszuk, and R. Prager. Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans. Diabetologia 34: 52-54, 1991.
16. Johnson, K. H., T. D. O'Brien, and P. Westermark. Newly identified pancreatic protein islet amyloid polypeptide. What is its relationship to diabetes? Diabetes 40: 310-314, 1991.
17. Kahn, S. E. Regulation of B-cell function in vivo: from health to disease. Diabetes Rev. 4: 372-389, 1996.
18. Kahn, S. E., J. C. Beard, M. W. Schwartz, W. K. Ward, H. L. Ding, R. N. Bergman, G. J. Taborsky, Jr., and D. Porte, Jr. Increased β-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes 38: 562-568, 1989.
19. Kahn, S. E., D. A. D'Alessio, M. W. Schwartz, W. Y. Fujimoto, J. W. Ensinck, G. J. Taborsky, Jr., and D. Porte, Jr. Evidence of cosecretion of islet amyloid polypeptide and insulin by β-cells. Diabetes 39: 634-638, 1990.
20. Kahn, S. E., W. Y. Fujimoto, D. A. D'Alessio, J. W. Ensinck, and D. Porte, Jr. Glucose stimulates and potentiates islet amyloid polypeptide secretion by the B-cell. Horm. Metab. Res. 23: 577-580, 1991.